vTv Therapeutics Statistics
NASDAQ: VTVTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
30.76+0.68 (+2.26%)
Market open · Delayed 15 min · as of Oct 9, 10:14 AM ET
vTv Therapeutics by the numbers
vTv Therapeutics has a market capitalization of $121.6 million based on 3.95M shares outstanding. With trailing EPS of $-0.72, vTv Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.0% below its 50-day average and 10.7% below its 200-day average.
Average daily trading volume is 68.13K shares, or about $2.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VTVT valuation vs. peer median
| Metric | VTVT | Peer median | Difference |
|---|---|---|---|
| Market cap | $121.62M | $115.91M | +5% |
| Avg. volume | 68.13K | 676.32K | -90% |
Peer median across 8 companies: PMVP, FHTX, COYA, INO, GNLX, QUCY, NRXP, RANI.
Valuation
- Market cap
- $121.62M
- EPS (TTM)
- $-0.72
- Shares outstanding
- 3.95M
Price and trading
- Previous close
- 30.08
- Open
- 30.16
- Day range
- 30.16 – 30.77
- 52-week range
- 19.50 – 44.00
- 52-week change
- +35.99%
- Beta
- —
- Volume
- 1.51K
- Average volume
- 68.13K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 121.62M
- Forward Pe
- -6.54
- Eps
- -0.72
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 44.00
- Week52 Low
- 19.50
- Avg Volume
- 68,126.00
- Shares Outstanding
- 3.95M
- Ma50
- 32.03
- Ma200
- 34.43
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -30.09%
- Pct From52w Low
- 57.74%